Clinical Trials in Sun City West, Arizona

Find clinical trials in Sun City West, Arizona. Discover local research opportunities and treatment options in your area.

6 Active Trials Found in Sun City West

Showing 6 trials on this page

Page 1 of 1

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT ID: NCT06383390

The TRIUMPH-OUTCOMES study is looking at a new treatment called retatrutide, which is given once a week, to see if it can help reduce serious heart problems and protect kidney function in adults wh...

Recruiting

Phase: PHASE3 Conditions: Chronic Kidney Disease (CKD), Atherosclerotic Cardiovascular Disease (ASCVD)

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

NCT ID: NCT03072927

This clinical trial is studying a procedure called MILD® (Minimally Invasive Lumbar Decompression) for patients with a condition known as lumbar spinal stenosis, which means there is pressure on th...

Recruiting

Conditions: Lumbar Spinal Stenosis

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT ID: NCT07064473

This clinical trial is studying whether a new medicine called vicadrostat, when taken together with an existing diabetes medicine called empagliflozin, can help lower the risk of heart problems in ...

Not yet recruiting

Phase: PHASE3 Conditions: Hypertension, Diabetes Mellitus, Type 2 +1 more

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

NCT ID: NCT06297603

This clinical trial, called TRANSCEND-T2D-3, is exploring the effectiveness and safety of a new medication called retatrutide for people with Type 2 diabetes who also have moderate or severe kidney...

Recruiting

Phase: PHASE3 Conditions: Type 2 Diabetes

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

NCT ID: NCT07000123

This clinical trial is studying a new medication called AZD0780, which is designed to lower levels of LDL cholesterol (often referred to as "bad" cholesterol) in the blood. The trial is for adults ...

Recruiting

Phase: PHASE3 Conditions: Cardiovascular Disease

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

NCT ID: NCT06292013

The ACCLAIM-Lp(a) trial is studying a new treatment called lepodisiran to see if it can help reduce the risk of serious heart problems in adults who have high levels of a substance called lipoprote...

Recruiting

Phase: PHASE3 Conditions: Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)

Search All Trials Browse All Locations